📋 Clinical Overview

Carbimazole is a thioamide antithyroid drug, classified as a pro-drug, used primarily for the management of hyperthyroidism, including Graves' disease. It acts by inhibiting the synthesis of thyroid hormones (T3 and T4) in the thyroid gland. In the Indian context, it is a first-line oral therapy for controlling thyrotoxicosis prior to definitive therapy (radioiodine or surgery) and for long-term medical management.

💊 Dosage & Administration

Adult: Initial: 15-40 mg daily, administered in 2-3 divided doses. A typical starting dose for moderate Graves' is 20-30 mg/day. Maintenance: 5-15 mg daily, often as a single daily dose. Titration is based on TFTs every 4-6 weeks.
Pediatric: Initial: 0.4-0.7 mg/kg/day or 15-20 mg/m²/day, divided into 2-3 doses. Maintenance: Approximately half the initial dose, adjusted based on TFTs.
Renal Adjusment: No specific dosage adjustment required in renal impairment. Use with caution in severe renal failure.
Hepatic Adjusment: Use with extreme caution. Start with lowest possible dose and monitor liver function tests closely. Contraindicated in severe hepatitis.
Instruction: Administer orally with or without food. Food may slightly delay absorption but does not affect overall bioavailability. Tablets should be swallowed whole with a glass of water. Consistent timing of doses is recommended. For maintenance single daily dose, morning administration is common.

⚠️ Contraindications

Known hypersensitivity to carbimazole, methimazole, or any component of the formulation
Previous history of severe adverse reactions (e.g., agranulocytosis, severe hepatitis) to carbimazole or related thioamides
Treatment of hyperthyroidism in pregnancy - especially in the first trimester (safer alternatives like Propylthiouracil are preferred in India for 1st trimester, though carbimazole can be used in 2nd/3rd trimester with caution).

🔬 Mechanism of Action

Carbimazole is a pro-drug rapidly converted to its active form, methimazole. It inhibits the enzyme thyroid peroxidase (TPO) within the thyroid follicular cells. TPO is crucial for the oxidation of iodide to iodine, iodination of tyrosine residues on thyroglobulin, and coupling of iodotyrosines (MIT and DIT) to form the active thyroid hormones triiodothyronine (T3) and thyroxine (T4). By blocking these steps, it reduces the synthesis of new thyroid hormones.

🤕 Side Effects

Mild skin rash or urticaria
Arthralgia (joint pain)
Nausea, gastrointestinal upset
Mild transient leukopenia
Altered taste sensation
Hair loss (usually reversible)

🤰 Special Populations

Pregnancy: Pregnancy Category D (as per some references). Crosses placenta and can cause fetal hypothyroidism and goiter. In India, Propylthiouracil (PTU) is the drug of choice for the first trimester due to lower transplacental passage and less association with fetal anomalies (like aplasia cutis). Carbimazole may be considered in the second and third trimester if needed, at the lowest effective dose. Close monitoring of maternal TFTs and fetal thyroid status (via ultrasound) is essential.

Lactation: Excreted in breast milk in small amounts. Considered compatible with breastfeeding by many guidelines if the maternal dose is ≤20-30 mg/day. Monitor infant's thyroid function if on high doses. Advise mother to take dose after breastfeeding.

Alcohol: No direct interaction. However, alcohol may exacerbate dizziness or gastrointestinal side effects. Patients with liver impairment should avoid alcohol.

Driving: Usually no effect. However, dizziness or generalized weakness, especially at initiation of therapy or if over-treated leading to hypothyroidism, may impair ability to drive or operate machinery.

🔄 Drug Interactions

Warfarin/Anticoagulants: Carbimazole may potentiate anticoagulant effect by reducing vitamin K-dependent clotting factor synthesis (due to hypothyroidism) and possible displacement from protein binding. Monitor INR closely. Major
Digoxin: Hyperthyroidism increases digoxin clearance. As carbimazole treats hyperthyroidism, digoxin levels may rise, risking toxicity. Reduce digoxin dose as thyroid status normalizes. Major
Beta-blockers (e.g., Propranolol): Additive symptomatic control of tachycardia and tremors. No significant PK interaction. Minor
Theophylline: Hyperthyroidism increases theophylline clearance. Normalization of thyroid function with carbimazole may increase theophylline levels, risking toxicity. Moderate
Lithium: Concurrent use may have additive antithyroid effects and increase risk of hypothyroidism. Lithium levels should be monitored. Moderate
Iodine/Amiodarone: May reduce the response to carbimazole and prolong the time to achieve euthyroid state. Moderate

🔁 Alternatives to Thyrozol (Note: Thyrozol is Methimazole, not Carbimazole. Included for differentiation)

Same composition (Carbimazole (5mg)), different brands:

Neomercazole Thyrocab Carbimazole Antithyrox